Concourse Financial Group Securities’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-898
Closed -$292K 2404
2024
Q1
$292K Buy
898
+7
+0.8% +$1.72K 0.02% 567
2023
Q4
$170K Buy
891
+134
+18% +$25.3K 0.01% 707
2023
Q3
$151K Buy
757
+147
+24% +$34.8K 0.01% 707
2023
Q2
$174K Sell
610
-356
-37% -$98.9K 0.01% 682
2023
Q1
$209K Buy
966
+269
+39% +$52.4K 0.02% 633
2022
Q4
$143K Buy
697
+558
+401% +$141K 0.01% 716
2022
Q3
$39K Buy
139
+8
+6% +$2.03K ﹤0.01% 1053
2022
Q2
$25K Buy
+131
New +$23.1K ﹤0.01% 1377
2022
Q1
Sell
-90
Closed -$14.8K 2484
2021
Q4
$16K Hold
90
﹤0.01% 1733
2021
Q3
$19K Hold
90
﹤0.01% 1685
2021
Q2
$17K Hold
90
﹤0.01% 1700
2021
Q1
$12K Hold
90
﹤0.01% 1728
2020
Q4
$9K Hold
90
﹤0.01% 1738
2020
Q3
$7K Hold
90
﹤0.01% 1706
2020
Q2
$4K Hold
90
﹤0.01% 1784
2020
Q1
$3K Hold
90
﹤0.01% 1830
2019
Q4
$4K Buy
+90
New +$3.32K ﹤0.01% 1724
2019
Q3
Sell
-90
Closed -$3.82K 2207
2019
Q2
$5K Buy
+90
New +$4.37K ﹤0.01% 1766

Other funds holding SWAV

Concourse Financial Group Securities's SWAV Position: Q2 2024 in Review

Concourse Financial Group Securities sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 898 shares — an estimated $292K sold.

Concourse Financial Group Securities first reported a position in SWAV in Q2 2019 and held it in 18 quarters. The position peaked at $292K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Concourse Financial Group Securities reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 898 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $292K.
  • Concourse Financial Group Securities first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
  • Concourse Financial Group Securities's Shockwave Medical, Inc. Common Stock position peaked at $292K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Concourse Financial Group Securities's 13F filing for Q2 2024, filed 23 Jul 2024.